Iovance Biotherapeutics Inc
NASDAQ:IOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
US |
|
Aleatica SAB de CV
BMV:ALEATIC
|
MX |
|
Subsea 7 SA
OSE:SUBC
|
UK |
|
U
|
United Parcel Service Inc
LSE:0R08
|
US |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
C
|
Compal Electronics Inc
TWSE:2324
|
TW |
|
Next 15 Group PLC
LSE:NFG
|
UK |
|
H
|
Halma PLC
OTC:HALMY
|
UK |
|
Coca Cola HBC AG
F:CCKC
|
CH |
|
P
|
Prudential PLC
XBER:PRU
|
UK |
|
N
|
Nephros Inc
F:NPJP
|
US |
|
Matador Resources Co
NYSE:MTDR
|
US |
|
Mitsubishi HC Capital Inc
OTC:MIUFF
|
JP |
|
Capital Ltd
F:C8D
|
UK |
|
H
|
Halma PLC
F:H11
|
UK |
|
Jfrog Ltd
NASDAQ:FROG
|
US |
|
Health Catalyst Inc
F:2YP
|
US |
|
C
|
China Shenhua Energy Co Ltd
OTC:CSUAY
|
CN |
|
Caseys General Stores Inc
NASDAQ:CASY
|
US |
|
GameStop Corp
BMV:GME
|
US |
Wall St Price Targets
IOVA Price Targets Summary
Iovance Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for
IOVA is 9.69 USD with a low forecast of 6.06 USD and a high forecast of 13.65 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IOVA's stock price target?
Price Target
9.69
USD
According to Wall Street analysts, the average 1-year price target for
IOVA is 9.69 USD with a low forecast of 6.06 USD and a high forecast of 13.65 USD.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Revenue over the next 8 years is 29%.
What is the Gross Profit forecast for Iovance Biotherapeutics Inc?
Projected CAGR
43%
The compound annual growth rate for Gross Profit over the next 8 years is 43%.